Pembrolizumab Treatment and Pathologic Therapeutic Evaluation for Granulocyte Colony-stimulating Factor-producing Bladder Cancer: A Case Report and Literature Review-Reference-Cited by-同舟云学术

Pembrolizumab Treatment and Pathologic Therapeutic Evaluation for Granulocyte Colony-stimulating Factor-producing Bladder Cancer: A Case Report and Literature Review

Published:2020-02-17 Issue:4 Volume:43 Page:134-138
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Muramatsu-Maekawa Yuka,Taniguchi Tomoki,Ito Hiroki,Nakane Keita,Kato Taku,Tsuchiya Tomohiro,Miyazaki Tatsuhiko,Koie Takuya,Mizutani Kosuke

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference42 articles.

1. Paraneoplastic production of granulocyte colony-stimulating factor in a bladder carcinoma;Turalic;Scand J Urol Nephrol,2006

2. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue;Asano;Blood,1977

3. G-CSF production in human bladder cancer and its ability to promote autocrine growth: a review;Tachibana;Cytokines Cell Mol Ther,1998

4. EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal;Jing;Cancer Med,2016

5. Leukemoid reaction, thrombocytosis and hypercalcemia associated with bladder cancer;Block;J Urol,1973

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Analysis of the Colony-Stimulating Factor 3 Gene of Granulocyte Colony-Stimulating Factor-Producing Urothelial Cancer;Cureus;2023-08-23

2. Favorable response to pembrolizumab in granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma;IJU Case Reports;2021-12-17

3. A Case of G-CSF Producing Breast Cancer in which Atezolizumab + Nab-paclitaxel Regimen was Effective;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2021